In addition, CD24Fc could rapidly down-modulate the systemic inflammation and could restore immune homeostasis in SARS-CoV-2-infected individuals (21), suggesting that CD24 targeting inflammation in response to tissue injuries could provide a promising therapeutic option for patients hospitalized with COVID-19. Here, CD24 is linked to COVID-19.